During the past decade, CancerCare Manitoba conducted 123 clinical trials. In the 10-year time frame, 123 clinical trials started and 146 clinical trials were completed, i.e. on average, 118.7% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 55 clinical trials were completed. i.e. 157.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CancerCare Manitoba" #1 sponsor was "Children's Oncology Group" with 117 trials, followed by "NCIC Clinical Trials Group" with 50 trials sponsored, "National Cancer Institute (NCI)" with 45 trials sponsored, "Canadian Cancer Trials Group" with 23 trials sponsored and "Alliance for Clinical Trials in Oncology" with 23 trials sponsored. Other sponsors include 189 different institutions and companies that sponsored additional 100 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CancerCare Manitoba" #1 collaborator was "National Cancer Institute (NCI)" with 178 trials as a collaborator, "NCIC Clinical Trials Group" with 31 trials as a collaborator, "SWOG Cancer Research Network" with 23 trials as a collaborator, "Cancer and Leukemia Group B" with 16 trials as a collaborator and "Eastern Cooperative Oncology Group" with 11 trials as a collaborator. Other collaborators include 334 different institutions and companies that were collaborators in the rest 217 trials.

According to Clinical.Site data, the most researched conditions in "CancerCare Manitoba" are "Breast Cancer" (33 trials), "Lymphoma" (20 trials), "Leukemia" (19 trials), "Prostate Cancer" (18 trials) and "Sarcoma" (17 trials). Many other conditions were trialed in "CancerCare Manitoba" in a lesser frequency.

Most popular intervention types in "CancerCare Manitoba" are "Drug" (340 trials), "Other" (126 trials), "Biological" (105 trials), "Radiation" (104 trials) and "Procedure" (87 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (60 trials), "Cyclophosphamide" (47 trials), "cyclophosphamide" (39 trials), "Vincristine Sulfate" (34 trials) and "radiation therapy" (32 trials). Other intervention names were less common.

The vast majority of trials in "CancerCare Manitoba" are 361 trials for "All" genders, 53 trials for "Female" genders and 30 trials for "Male" genders.

Currently, there are NaN active trials in "CancerCare Manitoba". undefined are not yet recruiting, 49 are recruiting, 94 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 254 completed trials in CancerCare Manitoba, 3 suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in CancerCare Manitoba, 21 "Phase 1" clinical trials were conducted, 139 "Phase 2" clinical trials and 241 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 24 trials that are defined as “Not Applicable".

CancerCare Manitoba has several departments that took part in Clinical trials: "CancerCare Manitoba; Neuro-Oncology" - 3 trials, "CancerCare Manitoba - St. Boniface" - 2 trials